Phenylketonurics is the term used on food and drug labels to warn people who have phenylketonuria (PKU), a genetic condition that prevents the body from properly processing an amino acid called phenylalanine. You’ve almost certainly seen this word on a diet soda can or sugar-free gum package, printed as: “Phenylketonurics: Contains Phenylalanine.” That warning exists because the artificial sweetener aspartame breaks down into roughly 50% phenylalanine during digestion, and for the roughly 1 in 25,000 people in the United States born with PKU, consuming too much phenylalanine can cause serious brain damage.
Why the Warning Label Exists
Federal regulations require every product containing aspartame to declare the presence of phenylalanine. For over-the-counter drugs, the label must even specify the exact milligrams per dose. This isn’t a general health warning for the average consumer. Phenylalanine is a normal, essential amino acid found in virtually all protein-containing foods, and it’s harmless for people without PKU. The label is specifically directed at the small number of people who cannot metabolize it safely.
Aspartame is about 180 times sweeter than sugar, so only tiny amounts are needed in products. But when your body digests it, the result is 50% phenylalanine, 40% aspartic acid, and 10% methanol. For someone with PKU who is carefully tracking every milligram of phenylalanine in their diet, an unlabeled source could throw off their entire daily intake.
What Phenylketonuria Actually Is
PKU is an inherited metabolic disorder present from birth. People with PKU have a nonfunctional or severely underperforming version of an enzyme that converts phenylalanine into another amino acid called tyrosine. Without this conversion happening properly, phenylalanine accumulates in the blood and brain to toxic levels.
The consequences are twofold. First, the excess phenylalanine gets converted into byproducts (including phenylpyruvic acid and phenylacetic acid) that are toxic to developing brain tissue. Second, because the normal conversion to tyrosine is blocked, the body runs short on several critical chemicals that tyrosine helps produce: dopamine, adrenaline, norepinephrine, thyroid hormone, and melanin. This is why untreated PKU can affect everything from cognition to skin pigmentation.
How PKU Is Detected
Every baby born in the United States is screened for PKU as part of routine newborn testing. Between 24 and 72 hours after birth, a healthcare provider pricks the baby’s heel and collects a few drops of blood. The test is timed this way deliberately: the baby needs to have consumed some breast milk or formula first so that phenylalanine from protein is circulating in the blood. If levels come back elevated, confirmatory testing follows. Because of universal newborn screening, PKU is almost always caught before any damage occurs.
What Happens Without Treatment
Left untreated, PKU causes progressive and irreversible neurological damage. The hallmark consequence is intellectual disability, but the effects extend further: seizures, tremor, problems with coordination and balance, behavioral disturbances, and impaired sensory and motor function. Adults with poorly controlled PKU can develop what’s called phenylketonuric encephalopathy, which involves cognitive problems with memory, verbal fluency, and spatial reasoning. The severity depends largely on how high phenylalanine levels climb and for how long.
The PKU Diet
The primary treatment for PKU is a strict, lifelong low-phenylalanine diet. Because phenylalanine is a component of protein, this means avoiding or severely restricting nearly all high-protein foods. The restricted list is extensive:
- Animal proteins: meat, chicken, fish, eggs, and cheese
- Grains: wheat, oats, rye, barley, and quinoa
- Legumes and soy: lentils, pulses, soya, and tempeh
- Nuts and seeds
- Other sources: gelatin, spirulina, and protein-based meat substitutes
People with PKU get most of their protein and essential nutrients from special medical formulas that provide amino acids without phenylalanine. Fruits, some vegetables, and specially manufactured low-protein foods (breads, pastas, rice substitutes) make up the bulk of solid food intake. In the United States, the recommended blood phenylalanine target is kept below 360 micromoles per liter throughout life, which requires regular blood monitoring and careful meal planning.
This diet is demanding. Every food choice involves calculating phenylalanine content, and eating out or sharing meals with others requires constant vigilance. For children, parents typically manage the diet closely. As people with PKU reach adulthood, maintaining strict dietary control becomes one of their biggest ongoing challenges.
Medications for PKU
Two FDA-approved medications now exist for PKU, both offering some relief from the dietary restrictions. The first, approved in 2007, works by boosting the activity of whatever residual enzyme function a person has. It’s effective for a subset of patients whose enzyme isn’t completely nonfunctional, allowing them to tolerate more dietary protein.
The second, approved in 2018, takes a different approach entirely. It’s an enzyme substitution therapy given as a daily injection that breaks down phenylalanine through an alternative pathway. For people who respond well, it can dramatically lower blood phenylalanine levels and allow significantly more natural protein in the diet, reducing dependence on medical formula. It’s currently approved for adults 18 and older with elevated phenylalanine levels. Neither medication eliminates the need for monitoring, but both represent meaningful options beyond diet alone.
How Common Is PKU
PKU affects roughly 1 in 10,000 to 1 in 25,000 live births in the United States, with an estimated 450,000 people living with PKU worldwide. The condition is most common among people of European descent, with Italy having one of the highest rates at about 1 in 4,500 births. Japan has one of the lowest rates at approximately 1 in 125,000. Rates also vary across the Americas: Canada sees about 1 in 15,000, Brazil roughly 1 in 25,000, and Peru around 1 in 47,000.
PKU is inherited in an autosomal recessive pattern, meaning a child must receive a defective copy of the gene from both parents to develop the condition. Parents who each carry one copy typically have no symptoms themselves and may not know they’re carriers until a child is diagnosed through newborn screening.